rs141292909
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_014467.3(SRPX2):c.1199A>G(p.Asn400Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000196 in 1,020,097 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014467.3 missense
Scores
Clinical Significance
Conservation
Publications
- rolandic epilepsy-speech dyspraxia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- polymicrogyria, bilateral perisylvian, X-linkedInheritance: XL Classification: LIMITED Submitted by: G2P
- rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linkedInheritance: XL Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SRPX2 | ENST00000373004.5 | c.1199A>G | p.Asn400Ser | missense_variant | Exon 10 of 11 | 1 | NM_014467.3 | ENSP00000362095.3 | ||
| SRPX2 | ENST00000638920.1 | n.1202A>G | non_coding_transcript_exon_variant | Exon 9 of 10 | 5 | |||||
| SRPX2 | ENST00000640282.1 | c.142-1456A>G | intron_variant | Intron 2 of 2 | 5 | ENSP00000491188.1 |
Frequencies
GnomAD3 genomes AF: 0.0000884 AC: 8AN: 90512Hom.: 0 Cov.: 18 show subpopulations
GnomAD2 exomes AF: 0.0000234 AC: 4AN: 170754 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000129 AC: 12AN: 929585Hom.: 0 Cov.: 31 AF XY: 0.0000132 AC XY: 4AN XY: 303159 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000884 AC: 8AN: 90512Hom.: 0 Cov.: 18 AF XY: 0.00 AC XY: 0AN XY: 20302 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 400 of the SRPX2 protein (p.Asn400Ser). This variant is present in population databases (rs141292909, gnomAD 0.03%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 207384). This variant has not been reported in the literature in individuals affected with SRPX2-related conditions. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at